These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2505991)

  • 1. Tissue-plasminogen activator: nursing implications.
    Briones TL
    Dimens Crit Care Nurs; 1989; 8(4):200-9. PubMed ID: 2505991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy orders and record sheets: nursing care made easier.
    Rafter RH
    J Emerg Nurs; 1988; 14(4):237-9. PubMed ID: 3137388
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
    Collen D; Van de Werf F
    Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of a single intravenous bolus injection of tissue-type plasminogen activator in acute myocardial infarction. Bolus Dose-Escalation Study of Tissue-Type Plasminogen Activator (BEST) Investigators.
    Hackett D; Andreotti F; Haider AW; Brunelli C; Shahi M; Fussell A; Buller N; Foale R; Lipkin D; Caponnetto S
    Am J Cardiol; 1992 Jun; 69(17):1393-8. PubMed ID: 1590225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator administration and nursing considerations.
    Greco A
    J Intraven Nurs; 1989; 12(1):20-4. PubMed ID: 2494313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue-type plasminogen activator in acute myocardial infarction: role of the critical care nurse.
    Kline EM
    Heart Lung; 1987 Nov; 16(6 Pt 2):779-86. PubMed ID: 2960639
    [No Abstract]   [Full Text] [Related]  

  • 7. The thrombolysis and angioplasty in myocardial infarction (TAMI) trial: review and nursing implications.
    Pitts P; Fenwick B; Fromberg B
    Prog Cardiovasc Nurs; 1990; 5(2):65-72. PubMed ID: 2116622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-type plasminogen activator: intracoronary applications.
    Tiefenbrunn AJ
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):108-15. PubMed ID: 2106393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
    Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic study of mutant tissue-type plasminogen activator versus urokinase for acute myocardial infarction.
    Nagao K; Satou K; Watanabe I; Arima K; Yamashita M; Ooiwa K; Kanmatsuse K
    Jpn Circ J; 1998 Feb; 62(2):111-4. PubMed ID: 9559429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing coronary artery reocclusion following t-PA.
    Sylvain Moore H
    Crit Care Nurse; 1990; 10(10):52-8. PubMed ID: 2123427
    [No Abstract]   [Full Text] [Related]  

  • 13. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
    Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
    Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
    Sherry S
    Am J Cardiol; 1987 Apr; 59(9):984-9. PubMed ID: 3105303
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.
    Williams DO; Borer J; Braunwald E; Chesebro JH; Cohen LS; Dalen J; Dodge HT; Francis CK; Knatterud G; Ludbrook P
    Circulation; 1986 Feb; 73(2):338-46. PubMed ID: 3080261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of new thrombolytic substances].
    Zeymer U; Neuhaus KL
    Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue plasminogen activator: an evaluation of clinical efficacy in acute myocardial infarction.
    Rogers SD; Riemersma LB; Clements SD
    Pharmacotherapy; 1987; 7(4):111-21. PubMed ID: 3120160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent nitroglycerin therapy impairs tissue-type plasminogen activator-induced thrombolysis in patients with acute myocardial infarction.
    Nicolini FA; Ferrini D; Ottani F; Galvani M; Ronchi A; Behrens PH; Rusticali F; Mehta JL
    Am J Cardiol; 1994 Oct; 74(7):662-6. PubMed ID: 7942523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.